Compare

Function Health vs InsideTracker

Both are subscription DTC biomarker services. Function Health offers a larger biannual panel; InsideTracker has longer history and stronger athletic-performance integration.

GrimAge vs DunedinPACE

Two of the most-used epigenetic clocks. GrimAge estimates cumulative biological age; DunedinPACE estimates the *rate* of biological aging from a single timepoint. They answer different questions.

NMN vs NR (NAD+ Precursors)

Both raise blood NAD+ in human trials. The mechanistic debate (Sinclair's Slc12a8 paper vs others) is largely settled in practical terms — both work; the differences between commercial products matter more than the mechanism.

Oura vs WHOOP

Both are subscription wearables focused on recovery, sleep, and HRV trends rather than exercise tracking. Oura is a ring; WHOOP is a strap. The differences in form factor and target audience drive most of the choice.

Rapamycin vs Metformin (for Longevity)

Both target conserved nutrient-sensing biology, but they differ enormously in evidence strength, side effects, and the populations who might benefit. Most discussions oversimplify.

Semaglutide vs Tirzepatide

Both are weekly injectable incretin-based therapies that produce substantial weight loss. Tirzepatide (dual GIP/GLP-1) typically delivers more weight loss; semaglutide has the larger cardiovascular outcomes evidence base.

Statins vs PCSK9 Inhibitors

Statins remain the foundation of LDL/apoB-lowering for most adults. PCSK9 inhibitors deliver larger absolute LDL reductions with cardiovascular outcome evidence; cost and access drive when they are used.

Zone 2 vs HIIT

Both extend life expectancy and improve cardiometabolic outcomes. They train different physiologies and complement rather than substitute for each other. The 80/20 rule from endurance training applies.